Role of companion dogs in cancer immunotherapy development
The Journal of Immunology · 01.10.2025 · 214 (10) · 2515-2522
DOI: 10.1093/jimmun/vkaf244 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Immunology, online erschienen am 31.10.2025. Verfasst von Lyndah Chow und 2 weiteren Autor:innen. Beteiligte Einrichtung: Flint Animal Cancer Center, Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort …. Hauptthemen laut MEDLINE: Neoplasms, Immunotherapy, Dog Diseases, Pets. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Public Health Service, Shipley Family Foundation, V Foundation.
Abstract (Originalsprache)
Rodent models for evaluating new cancer immunotherapies often fail to fully recapitulate the complexity of immune interactions that occur in cancer patients. Companion dogs with spontaneously developing cancers more closely resemble humans immunologically than rodents. This resemblance results in part because their immune systems have been educated early by repeated vaccinations and viral and bacterial infections, with further sculpting later in life by tumors that typically take months to develop. Moreover, dogs possess all of the major leukocyte subsets present in humans, both in circulation and within tumor tissues. The major canine cancer models most relevant to evaluating new cancer immunotherapies include osteosarcoma, glioma, non-Hodgkin lymphoma, melanoma, uroepithelial cancer, and head and neck cancers. Each of these cancers recapitulates to varying degrees the genetics, histology, and biological behaviors of the human analogous cancers. Immune therapies under active investigation in companion dogs include chimeric antigen receptor T-cell therapies, myeloid cell–targeted therapies, radioimmunotherapy, and tumor vaccines. Results of these ongoing studies are expected to accelerate the translation to humans of promising therapy combinations, while also identifying approaches that are ineffective or associated with unacceptable immunological toxicities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Flint Animal Cancer Center, Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, CO, United States.
Förderung
- Public Health Service
- Shipley Family Foundation
- V Foundation
Zitieren
APA
Chow, L., Ammons, D., & Dow, S. W. (2025). Role of companion dogs in cancer immunotherapy development. The Journal of Immunology, 214(10), 2515-2522. https://doi.org/10.1093/jimmun/vkaf244
Vancouver
Chow L, Ammons D, Dow SW. Role of companion dogs in cancer immunotherapy development. The Journal of Immunology. 2025;214(10):2515-2522. doi:10.1093/jimmun/vkaf244
BibTeX
@article{Chow2025,
author = {Chow, Lyndah and Ammons, Dylan and Dow, Steven W},
title = {Role of companion dogs in cancer immunotherapy development},
journal = {The Journal of Immunology},
year = {2025},
volume = {214},
number = {10},
pages = {2515--2522},
doi = {10.1093/jimmun/vkaf244}
}
EUVIMED